MitraClip / Transcatheter Edge-to-Edge Repair (TEER) Procedure for International Patients in India
www.indiacardiacsurgerysite.com
Nov. 10, 2026, 11:21 p.m.
Transcatheter edge-to-edge repair (TEER), exemplified by the MitraClip device, represents a catheter-based treatment option for patients with significant mitral regurgitation. Rather than replacing the valve, MitraClip grasps and joins the anterior and posterior mitral leaflets to create an effective seal and reduce backward leakage. However, TEER is not a universal alternative to surgical repair; patient selection depends critically on whether mitral regurgitation is primary or secondary, symptom severity, ventricular function, optimization of medical therapy, surgical risk, leaflet anatomy, and pulmonary pressure. For clinically stable patients with confirmed severe mitral regurgitation and Heart Team recommendation, TEER offers advantages including minimally invasive access through the groin, shorter hospitalization (typically 7-14 days), and cost-effectiveness compared to Western countries. Indian tertiary centers provide structural-heart expertise, 3D echocardiography, and cardiac surgery backup. However, appropriate patient selection remains paramount, and unstable patients should stabilize locally first. Remote TEE image review can guide whether TEER, surgical repair, or optimized heart-failure treatment best serves individual patients.